TMC/RESPIRATORY PHARMACOLOGY EXAM – QUESTIONS AND
ANSWERS | VERIFIED AND WELL DETAILED ANSWERS | PLUS
RATIONALES | GUARANTEED PASS | LATEST EXAM UPDATE
Core Domains:
Bronchodilator Agents and Mechanisms
Anti-inflammatory Respiratory Medications
Aerosol Delivery Devices and Principles
Cardiopulmonary Pathophysiology and Drug Interactions
Emergency Respiratory Medications and Resuscitation
Pharmacokinetics and Pharmacodynamics in Respiratory Care
Introduction:
The purpose of this comprehensive assessment is to evaluate
advanced competency and clinical readiness in respiratory
pharmacology. This exam rigorously tests essential knowledge
regarding drug classifications, mechanisms of action, clinical
indications, adverse effects, and aerosol administration techniques.
Utilizing a combination of multiple-choice questions and complex, real-
world clinical scenarios, the assessment measures the candidate’s
ability to synthesize pharmacological principles and make critical,
evidence-based decisions in patient care settings. Emphasis is placed
on practical therapeutic applications, patient safety, dosage
calculations, and optimal management of acute and chronic
cardiopulmonary diseases.
SECTION ONE: QUESTIONS 1–100
,Question 1
A patient with severe asthma is prescribed an inhaled corticosteroid.
Which cellular mechanism best describes the primary anti-inflammatory
action of this medication class?
A. Inhibition of cyclooxygenase-1 enzymes
B. Upregulation of beta-2 adrenergic receptors
C. Suppression of multiple inflammatory genes via histone
deacetylation
D. Blockade of leukotriene receptors on smooth muscle
🟢 Correct answer: C
🔴 Explanation: Inhaled corticosteroids exert their primary anti-
inflammatory effect by binding to glucocorticoid receptors, translocating
to the nucleus, and recruiting histone deacetylases to suppress the
transcription of pro-inflammatory genes.
Question 2
A 45-year-old male with chronic obstructive pulmonary disease (COPD)
is prescribed a long-acting muscarinic antagonist (LAMA). What is the
primary pharmacological action of this drug class?
A. Stimulation of adenylate cyclase to increase cyclic AMP
B. Competitive inhibition of acetylcholine at M3 receptors
C. Direct relaxation of bronchial smooth muscle via phosphodiesterase
inhibition
D. Stabilization of mast cell membranes to prevent degranulation
🟢 Correct answer: B
🔴 Explanation: LAMAs, such as tiotropium, act as competitive
antagonists at muscarinic M3 receptors on airway smooth muscle,
preventing acetylcholine-induced bronchoconstriction.
Question 3
Which of the following short-acting beta-2 agonists (SABA) has the
fastest onset of action when delivered via metered-dose inhaler?
A. Salmeterol
B. Formoterol
C. Albuterol
D. Levalbuterol
,🟢 Correct answer: C
🔴 Explanation: Albuterol has a rapid onset of action (typically within 5
to 15 minutes), making it the standard rescue medication for acute
bronchospasm.
Question 4
During the administration of a nebulized bronchodilator, a patient
develops skeletal muscle tremor and tachycardia. Which receptor
stimulation is responsible for these systemic side effects?
A. Alpha-1 adrenergic receptors
B. Beta-2 adrenergic receptors
C. Muscarinic receptors
D. Histamine H1 receptors
🟢 Correct answer: B
🔴 Explanation: Systemic absorption of beta-2 agonists frequently
leads to activation of beta-2 receptors in skeletal muscle (causing
tremors) and reflex or direct stimulation of beta receptors in the heart
(causing tachycardia).
Question 5
What is the primary clinical indication for administering racemic
epinephrine via small volume nebulizer?
A. Chronic bronchitis exacerbation
B. Post-extubation laryngeal edema
C. Acute severe asthma refractory to albuterol
D. Cystic fibrosis mucolytic therapy
🟢 Correct answer: B
🔴 Explanation: Racemic epinephrine possesses alpha-1 adrenergic
vasoconstrictive properties, which rapidly reduce mucosal edema in the
upper airway, making it ideal for conditions like croup or post-extubation
laryngeal edema.
Question 6
A patient with cystic fibrosis is prescribed dornase alfa (Pulmozyme).
What is the precise mechanism of action of this mucolytic agent?
A. Breaking disulfide bonds in mucus glycoproteins
B. Hydrolyzing extracellular DNA present in purulent secretions
, C. Increasing fluid transport across the airway epithelium via sodium
channel blockade
D. Stimulating ciliary beat frequency through adenosine receptor
activation
🟢 Correct answer: B
🔴 Explanation: Dornase alfa is a recombinant human
deoxyribonuclease (rhDNase) that selectively cleaves DNA released
from degenerating neutrophils in the sputum of cystic fibrosis patients,
significantly reducing mucus viscosity.
Question 7
Which of the following medications is classified as a leukotriene
receptor antagonist?
A. Zileuton
B. Omalizumab
C. Montelukast
D. Theophylline
🟢 Correct answer: C
🔴 Explanation: Montelukast is an oral leukotriene receptor antagonist
that blocks the cysteinyl leukotriene receptors, reducing
bronchoconstriction and inflammation in asthma and allergic rhinitis.
Question 8
A respiratory therapist is calculating the optimal dosage of a medication.
Which pharmacokinetic parameter describes the time required for the
concentration of a drug in the body to decrease by fifty percent?
A. Bioavailability
B. Clearance
C. Half-life
D. Volume of distribution
🟢 Correct answer: C
🔴 Explanation: Half-life is defined as the time required for the plasma
concentration of a drug to reach half of its original value, which guides
dosing frequency.
ANSWERS | VERIFIED AND WELL DETAILED ANSWERS | PLUS
RATIONALES | GUARANTEED PASS | LATEST EXAM UPDATE
Core Domains:
Bronchodilator Agents and Mechanisms
Anti-inflammatory Respiratory Medications
Aerosol Delivery Devices and Principles
Cardiopulmonary Pathophysiology and Drug Interactions
Emergency Respiratory Medications and Resuscitation
Pharmacokinetics and Pharmacodynamics in Respiratory Care
Introduction:
The purpose of this comprehensive assessment is to evaluate
advanced competency and clinical readiness in respiratory
pharmacology. This exam rigorously tests essential knowledge
regarding drug classifications, mechanisms of action, clinical
indications, adverse effects, and aerosol administration techniques.
Utilizing a combination of multiple-choice questions and complex, real-
world clinical scenarios, the assessment measures the candidate’s
ability to synthesize pharmacological principles and make critical,
evidence-based decisions in patient care settings. Emphasis is placed
on practical therapeutic applications, patient safety, dosage
calculations, and optimal management of acute and chronic
cardiopulmonary diseases.
SECTION ONE: QUESTIONS 1–100
,Question 1
A patient with severe asthma is prescribed an inhaled corticosteroid.
Which cellular mechanism best describes the primary anti-inflammatory
action of this medication class?
A. Inhibition of cyclooxygenase-1 enzymes
B. Upregulation of beta-2 adrenergic receptors
C. Suppression of multiple inflammatory genes via histone
deacetylation
D. Blockade of leukotriene receptors on smooth muscle
🟢 Correct answer: C
🔴 Explanation: Inhaled corticosteroids exert their primary anti-
inflammatory effect by binding to glucocorticoid receptors, translocating
to the nucleus, and recruiting histone deacetylases to suppress the
transcription of pro-inflammatory genes.
Question 2
A 45-year-old male with chronic obstructive pulmonary disease (COPD)
is prescribed a long-acting muscarinic antagonist (LAMA). What is the
primary pharmacological action of this drug class?
A. Stimulation of adenylate cyclase to increase cyclic AMP
B. Competitive inhibition of acetylcholine at M3 receptors
C. Direct relaxation of bronchial smooth muscle via phosphodiesterase
inhibition
D. Stabilization of mast cell membranes to prevent degranulation
🟢 Correct answer: B
🔴 Explanation: LAMAs, such as tiotropium, act as competitive
antagonists at muscarinic M3 receptors on airway smooth muscle,
preventing acetylcholine-induced bronchoconstriction.
Question 3
Which of the following short-acting beta-2 agonists (SABA) has the
fastest onset of action when delivered via metered-dose inhaler?
A. Salmeterol
B. Formoterol
C. Albuterol
D. Levalbuterol
,🟢 Correct answer: C
🔴 Explanation: Albuterol has a rapid onset of action (typically within 5
to 15 minutes), making it the standard rescue medication for acute
bronchospasm.
Question 4
During the administration of a nebulized bronchodilator, a patient
develops skeletal muscle tremor and tachycardia. Which receptor
stimulation is responsible for these systemic side effects?
A. Alpha-1 adrenergic receptors
B. Beta-2 adrenergic receptors
C. Muscarinic receptors
D. Histamine H1 receptors
🟢 Correct answer: B
🔴 Explanation: Systemic absorption of beta-2 agonists frequently
leads to activation of beta-2 receptors in skeletal muscle (causing
tremors) and reflex or direct stimulation of beta receptors in the heart
(causing tachycardia).
Question 5
What is the primary clinical indication for administering racemic
epinephrine via small volume nebulizer?
A. Chronic bronchitis exacerbation
B. Post-extubation laryngeal edema
C. Acute severe asthma refractory to albuterol
D. Cystic fibrosis mucolytic therapy
🟢 Correct answer: B
🔴 Explanation: Racemic epinephrine possesses alpha-1 adrenergic
vasoconstrictive properties, which rapidly reduce mucosal edema in the
upper airway, making it ideal for conditions like croup or post-extubation
laryngeal edema.
Question 6
A patient with cystic fibrosis is prescribed dornase alfa (Pulmozyme).
What is the precise mechanism of action of this mucolytic agent?
A. Breaking disulfide bonds in mucus glycoproteins
B. Hydrolyzing extracellular DNA present in purulent secretions
, C. Increasing fluid transport across the airway epithelium via sodium
channel blockade
D. Stimulating ciliary beat frequency through adenosine receptor
activation
🟢 Correct answer: B
🔴 Explanation: Dornase alfa is a recombinant human
deoxyribonuclease (rhDNase) that selectively cleaves DNA released
from degenerating neutrophils in the sputum of cystic fibrosis patients,
significantly reducing mucus viscosity.
Question 7
Which of the following medications is classified as a leukotriene
receptor antagonist?
A. Zileuton
B. Omalizumab
C. Montelukast
D. Theophylline
🟢 Correct answer: C
🔴 Explanation: Montelukast is an oral leukotriene receptor antagonist
that blocks the cysteinyl leukotriene receptors, reducing
bronchoconstriction and inflammation in asthma and allergic rhinitis.
Question 8
A respiratory therapist is calculating the optimal dosage of a medication.
Which pharmacokinetic parameter describes the time required for the
concentration of a drug in the body to decrease by fifty percent?
A. Bioavailability
B. Clearance
C. Half-life
D. Volume of distribution
🟢 Correct answer: C
🔴 Explanation: Half-life is defined as the time required for the plasma
concentration of a drug to reach half of its original value, which guides
dosing frequency.
